Probiotics (Lactobacillus gasseri)Probiotics (Lactobacillus gasseri)
gut_health
别名: L. gasseri SBT2055, L. gasseri BNR17, Lactobacillus gasseri
About
A strain-specific probiotic with the most consistent clinical evidence among probiotic strains for supporting healthy visceral fat levels. A well-designed 12-week RCT using abdominal CT imaging demonstrated L. gasseri SBT2055 may support healthy body weight and abdominal fat distribution.
How It Works
Strain-specific probiotic that modulates the gut-brain-adipose axis. L. gasseri SBT2055 reduces dietary fat absorption by increasing fecal fat excretion (by ~8-18%), reduces pro-inflammatory cytokine production in visceral adipose tissue, and modulates bile acid metabolism. Also influences leptin and ghrelin signaling through short-chain fatty acid (SCFA) production and vagal nerve pathways.
Evidence For Conditions
| 健康状况 | 等级 | 研究数量 | 受试者 | |
|---|---|---|---|---|
| Abdominal Fat Reduction | A | 5 | 400 | 查看 → |
| Obesity | C | 15 | 1500 | 查看 → |
Side Effects
- Bloating (initial colonization)
- Gas
- GI discomfort (transient)
Drug & Supplement Interactions
- Immunosuppressants (probiotics may stimulate immune system)
- Antibiotics (may reduce probiotic effectiveness)
请务必告知您的医疗保健提供者您正在服用的所有补充剂。
Related Ingredients
FDA 免责声明: 这些声明未经美国食品药品监督管理局(FDA)评估。本网站上的产品和信息无意用于诊断、治疗、治愈或预防任何疾病。所展示的证据等级基于我们对已发表的同行评审研究的分析,不构成医疗建议。在开始任何补充剂方案之前,请务必咨询您的医疗保健提供者。